Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Osteo-Buddy, Usual Care.
- Who it may be relevant to
- Registry conditions: Osteoporosis Risk, Osteoporosis, Postmenopausal. Basic parameters: from 50 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Improving Both Health in Women With the Use of Osteo-Buddy to Enhance Osteoporosis Knowledge - A Mixed Method Clinical Trial
Overview
This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.
Detailed description
This study will involve evaluating the preliminary effectiveness and feasibility outcomes of the use of Osteo-Buddy, a Virtual Health Assistant (VHA), in improving the knowledge of osteoporosis in women aged 50 and above.
Interventions
- Other Osteo-Buddy
Osteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with: 1. Evaluating their risk level of osteoporosis 2. Recommending screening and referrals 3. Lifestyle interventions through motivation, education and tailored guidance As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data. - Other Usual Care
Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'
Primary outcome measures
- Osteoporosis Prevention and Awareness Tool (OPAAT) score [Time frame: On enrolment and 6-8 weeks post enrolment]
- System Usability Scale (SUS) [Time frame: 6-8 weeks post enrolment]
Secondary outcome measures (3)
- Recruitment rate [Time frame: over the course of recruitment, estimated 3-4 months]
- Retention rate [Time frame: 6-8 weeks post-enrolment]
- Utility rate [Time frame: 4 weeks]
Eligibility criteria
Inclusion criteria
- Age 50 and above
- Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score
- Not undertaken Bone Mineral Density (BMD) scan
- Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab
- Able to read and speak English
- Currently use and own a smartphone where Osteo-Buddy can be used
Exclusion criteria
- Known terminal illness
- Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07034131 · 2025-0064